Cancer Clinical Trials: Implications for Oncology Nurses

被引:5
|
作者
Portier, Wendy S. [1 ]
机构
[1] Portier & Associates LLC, New Orleans, LA USA
关键词
clinical trial; Food and Drug Administration; biomarker; informed consent; protocol; adverse event; clinical trial navigator;
D O I
10.1016/j.soncn.2020.150998
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To explore the various types and phases of clinical trials, the regulatory oversight, drug approval process, and implications of clinical trials for the oncology nurse. Data Sources: Peer-reviewed journal articles, internet, book chapters, white papers. Conclusion: Oncology nurses' interactions with patients entered on clinical trial and communication with the clinical research team is crucial to the successful conduct of clinical trials. The oncology nurse must work in concert with the clinical research team to protect patient safety and to produce accurate information for protocol requirements that will be used to evaluate whether a drug becomes approved or not by the US Food and Drug Administration. Implications for Nursing Practice: Oncology nurses play a central role to the successful outcome of clinical research studies. Nurses must work in close collaboration with the clinical research teams for the successful completion and adherence of the clinical trial and to maintain the safety of the patient enrolled into clinical trial. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Crossover in oncology clinical trials
    Diaz, Jose
    Sternberg, Cora N.
    Mehmud, Faisal
    Delea, Thomas E.
    Latimer, Nicholas
    Bartlett-Pandite, Arundathy N.
    Motzer, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Clinical trials of interventional oncology
    Arai, Yasuaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (04) : 301 - 305
  • [43] Clinical trials in neurosurgical oncology
    Murphy, Meghan
    Parney, Ian F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 119 (03) : 569 - 576
  • [44] Clinical Trials in Precision Oncology
    Mockus, Susan M.
    Patterson, Sara E.
    Statz, Cara
    Bult, Carol J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY, 2016, 62 (03) : 442 - 448
  • [45] Endpoints of clinical trials in oncology
    Roila, F
    Del Favero, A
    Ballatori, E
    TUMORI JOURNAL, 1997, 83 (06): : S8 - S13
  • [46] Adaptive clinical trials in oncology
    Berry, Donald A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (04) : 199 - 207
  • [47] Clinical trials in neurosurgical oncology
    Meghan Murphy
    Ian F. Parney
    Journal of Neuro-Oncology, 2014, 119 : 569 - 576
  • [48] Radiation oncology clinical trials
    Hynds, S.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S32 - S33
  • [49] Clinical Trials in Hematology and Oncology
    Einsele, Hermann
    Steutel, Han
    Eichhorst, Barbara
    Gobeler, Maria-Elisabeth
    Hochhaus, Andreas
    Nickel, Lars
    von Messling, Veronika
    Deggerich, Anke
    Nettekoven, Gerd
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 : 6 - 32
  • [50] Adaptive clinical trials in oncology
    Donald A. Berry
    Nature Reviews Clinical Oncology, 2012, 9 : 199 - 207